Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, and Nitto Denko Avecia, Inc. a leading contract development and ...
- The next frontier in oligonucleotide synthesis is the direct synthesis of gene-length sequences. - Ansa synthesized a 1005 base long oligonucleotide with industry-leading accuracy. - Ansa will be ...
Dublin, Oct. 03, 2025 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Market Report by Product, Application, End Use, and Region 2025-2033" has been added to ResearchAndMarkets.com's offering. The ...
In today’s fast-paced and competitive biotechnology landscape, control and speed define success for companies and core labs ...
DUBLIN--(BUSINESS WIRE)--The "Oligonucleotide Synthesis Market: Forecast by Oligo Length, Application, Category, Type, Product, and Region, with Executive and Consultant Guides" report has been added ...
Growing Importance of Peptide & Oligonucleotide TherapeuticsPeptides and oligonucleotides are transforming modern medicine.
The use of oligonucleotides as therapeutic agents is of great interest, particularly when it comes to siRNA and antisense oligonucleotides. However, the difficulty of targeting the right organ and ...
There’s been this dream for decades. What if we could just print out an entire gene directly, one base at a time? —Daniel Lin-Arlow, Ansa Biotechnologies As scientists set their sights on cell and ...
From synthetic biology and gene therapy to data storage and biofuel production, the demand for synthetic DNA is rising. (1) Chemicals remove the 5’-hydroxyl protecting group. The nucleosides are rich ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback